222 related articles for article (PubMed ID: 36730877)
1. Human Papillomavirus-Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review.
Okerosi S; Mokoh LW; Rubagumya F; Niyibizi BA; Nkya A; Van Loon K; Buckle G; Bent S; Ha P; Fagan JJ; Ng D; Aswani J; Xu MJ
JCO Glob Oncol; 2023 Jan; 9():e2200259. PubMed ID: 36730877
[TBL] [Abstract][Full Text] [Related]
2. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The "ALARM" study.
Agelaki S; Boukovinas I; Athanasiadis I; Trimis G; Dimitriadis I; Poughias L; Morais E; Sabale U; Bencina G; Athanasopoulos C
Cancer Med; 2024 Feb; 13(3):e6916. PubMed ID: 38247106
[TBL] [Abstract][Full Text] [Related]
3. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
[TBL] [Abstract][Full Text] [Related]
4. Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
Morais E; El Mouaddin N; Schuurman S; De A
Vaccine; 2021 Sep; 39(39):5461-5473. PubMed ID: 34452775
[TBL] [Abstract][Full Text] [Related]
5. [Infection of human papillomavirus and head and neck cancer].
Song C; Zhang SK; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):39-43. PubMed ID: 36709118
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of oral human papillomavirus infection in healthy population and head and neck cancer.
Vani NV; Madhanagopal R; Swaminathan R; Ganesan TS
Cancer Med; 2023 May; 12(10):11731-11745. PubMed ID: 36846921
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus-Attributable Head and Neck Cancers in India-A Systematic Review and Meta-Analysis.
Vani NV; Rama R; Madhanagopal R; Vijayalakshmi R; Swaminathan R
JCO Glob Oncol; 2024 Mar; 10():e2300464. PubMed ID: 38513185
[TBL] [Abstract][Full Text] [Related]
8. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
Syst Rev; 2020 Apr; 9(1):88. PubMed ID: 32321580
[TBL] [Abstract][Full Text] [Related]
9. The BROADEN study: The design of an observational study to assess the absolute burden of HPV-related head and neck cancers.
Morais E; Kothari S; Chen YT; Roberts CS; Gómez-Ulloa D; Fenoll R; Lara N; Pavón MÀ; Waterboer T; Mehanna H; Giuliano AR; Mirghani H; Alemany L
Contemp Clin Trials; 2022 Apr; 115():106631. PubMed ID: 34838716
[TBL] [Abstract][Full Text] [Related]
10. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.
Cole L; Polfus L; Peters ES
PLoS One; 2012; 7(3):e32657. PubMed ID: 22448226
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma at One of the Largest Tertiary Care Centers in Sub-Saharan Africa.
Dapaah G; Hille J; Faquin WC; Whittaker J; Dittrich CM; Ebrahim AK; Schneider JW; van Wyk AC; Opperman J; Merven M; Naidoo K; Loock JW; Afrogheh AH
Arch Pathol Lab Med; 2022 Aug; 146(8):1018-1023. PubMed ID: 34871360
[TBL] [Abstract][Full Text] [Related]
12. Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.
Kutz JM; Rausche P; Gheit T; Puradiredja DI; Fusco D
BMC Public Health; 2023 May; 23(1):974. PubMed ID: 37237329
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
[TBL] [Abstract][Full Text] [Related]
14. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies.
Menezes FDS; Fernandes GA; Antunes JLF; Villa LL; Toporcov TN
Oral Oncol; 2021 Apr; 115():105177. PubMed ID: 33561611
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link - A Systematic Review.
Dodd RH; Waller J; Marlow LAV
Clin Oncol (R Coll Radiol); 2016 Jul; 28(7):421-439. PubMed ID: 26996812
[TBL] [Abstract][Full Text] [Related]
17. Do cutaneous human papillomavirus genotypes affect head and neck cancer? Evidence and bias-correction from a case-control study.
Al-Soneidar WA; Harper S; Madathil SA; Schlecht NF; Nicolau B
Cancer Epidemiol; 2022 Aug; 79():102205. PubMed ID: 35780522
[TBL] [Abstract][Full Text] [Related]
18. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
19. Examining the effect of Medicaid expansion on early detection of head and neck cancer of the oral cavity and pharynx by HPV-type and generosity of dental benefits.
Semprini J
Cancer Rep (Hoboken); 2023 Aug; 6(8):e1840. PubMed ID: 37248803
[TBL] [Abstract][Full Text] [Related]
20. HPV vaccination for prevention of head and neck cancer among men.
El Hussein MT; Dhaliwal S
Nurse Pract; 2023 Oct; 48(10):25-32. PubMed ID: 37751612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
